With increasing clinical trial activity in cytokine inhibitors, gene therapies, and precision therapies for pediatric and adult cases, the Rosai-Dorfman disease treatment market is projected to grow globally through 2033. https://www.datamintelligence.com/research-report/rosai-dorfman-disease-market